Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInterserve Regulatory News (IRV)

  • There is currently no data for IRV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EPT Disclosure

19 Jul 2006 07:59

Investec Bank (UK) Limited19 July 2006 DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(a) of the Takeover Code) 1. KEY INFORMATION Name of exempt principal trader INVESTEC BANK (UK) LTDCompany dealt in INTERSERVE PLCClass of relevant security to which the ORDINARY SHARESdealings being disclosed relate (Note 1) Date of dealing 18/07/2006 2. DEALINGS (Note 2) (a) Purchases and sales Total number of securities purchased Highest price paid (Note 3) Lowest price paid (Note 3) Total number of securities sold Highest price received (Note 3) Lowest price received (Note 3) 10,205 360.0 p 357.44 p (b) Derivatives transactions (other than options) Product name, Long/short (Note 4) Number of securities (Note 5) Price per unit (Note 3) e.g. CFD (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, selling, Number of securities Exercise Type, e.g. Expiry Option money purchasing, to which the option American,e.g. call option varying etc. relates (Note 5) price European etc. date paid/received per unit (Note 3) (ii) Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 3) 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relatingto the voting rights of any relevant securities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form isreferenced. If none, this should be stated. Date of disclosure 19/07/2006 Contact name GARY DARCH Telephone number 020 7597 4549 Name of offeree/offeror with which connected MACLELLAN GROUP PLCNature of connection (Note 6) ADVISER & BROKER Notes The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(a) of the Takeover Code) 1. KEY INFORMATION Name of exempt principal trader INVESTEC BANK (UK) LTDCompany dealt in ENODIS PLCClass of relevant security to which the ORDINARY SHARESdealings being disclosed relate (Note 1) Date of dealing 18/07/2006 2. DEALINGS (Note 2) (a) Purchases and sales Total number of securities purchased Highest price paid (Note 3) Lowest price paid (Note 3) Total number of securities sold Highest price received (Note 3) Lowest price received (Note 3) 25,000 215.0 p 215.0 p (b) Derivatives transactions (other than options) Product name, Long/short (Note 4) Number of securities (Note 5) Price per unit (Note 3) e.g. CFD (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, selling, Number of securities Exercise Type, e.g. Expiry Option money purchasing, to which the option American,e.g. call option varying etc. relates (Note 5) price European etc. date paid/received per unit (Note 3) (ii) Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 3) 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relatingto the voting rights of any relevant securities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form isreferenced. If none, this should be stated. Date of disclosure 19/07/2006 Contact name GARY DARCH Telephone number 020 7597 4549 Name of offeree/offeror with which connected ENODIS PLCNature of connection (Note 6) JOINT BROKER Notes The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(a) of the Takeover Code) 1. KEY INFORMATION Name of exempt principal trader INVESTEC BANK (UK) LTDCompany dealt in MACLELLAN GROUP PLCClass of relevant security to which the ORDINARY SHARESdealings being disclosed relate (Note 1) Date of dealing 18/07/2006 2. DEALINGS (Note 2) (a) Purchases and sales Total number of securities purchased Highest price paid (Note 3) Lowest price paid (Note 3) 12,329 113.0 p 112.0 p Total number of securities sold Highest price received (Note 3) Lowest price received (Note 3) (b) Derivatives transactions (other than options) Product name, Long/short (Note 4) Number of securities (Note 5) Price per unit (Note 3) e.g. CFD (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, selling, Number of securities Exercise Type, e.g. Expiry Option money purchasing, to which the option American,e.g. call option varying etc. relates (Note 5) price European etc. date paid/received per unit (Note 3) (ii) Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 3) 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relatingto the voting rights of any relevant securities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form isreferenced. If none, this should be stated. Date of disclosure 19/07/2006 Contact name GARY DARCH Telephone number 020 7597 4549 Name of offeree/offeror with which connected MACLELLAN GROUP PLCNature of connection (Note 6) ADVISER & BROKER Notes The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
9th Sep 20163:37 pmRNSDirector/PDMR Shareholding
25th Aug 20169:33 amRNSPublication of Half-Year Report 2016
24th Aug 20167:00 amRNSCONTRACT WIN
10th Aug 20167:00 amRNSHalf-Year Results
9th Aug 201610:59 amRNSDirector/PDMR Shareholding
8th Aug 20167:00 amRNSContract Extension
5th Aug 20162:19 pmRNSHolding(s) in Company
15th Jul 20163:31 pmRNSHolding(s) in Company
12th Jul 20162:47 pmRNSDirector/PDMR Shareholding
1st Jul 20163:21 pmRNSBlock listing Interim Review
28th Jun 20167:00 amRNSContract Win
14th Jun 20161:04 pmRNSDirector/PDMR Shareholding
27th May 20163:51 pmRNSDirector/PDMR Shareholding
26th May 20163:48 pmRNSDirector/PDMR Shareholding
18th May 20167:00 amRNSContract Win
16th May 20162:32 pmRNSDirector/PDMR Shareholding
13th May 20168:38 amRNSHolding(s) in Company
10th May 20162:46 pmRNSResult of AGM
10th May 20167:00 amRNSDirector/PDMR Shareholding
6th May 20167:00 amRNSTrading Update
5th May 20167:00 amRNSBoard Change
3rd May 20167:00 amRNSContract Win
27th Apr 20163:33 pmRNSDirector Declaration
19th Apr 20163:26 pmRNSDirector/PDMR Shareholding
18th Apr 20167:00 amRNSContract Win
14th Apr 20163:25 pmRNSDirector/PDMR Shareholding
13th Apr 20164:16 pmRNSDirector/PDMR Shareholding
6th Apr 20164:48 pmRNSDirector/PDMR Shareholding
31st Mar 201610:23 amRNSDirector/PDMR Shareholding
31st Mar 20169:18 amRNSTotal Voting Rights
30th Mar 20168:36 amRNSPublication of Annual Report
22nd Mar 20163:13 pmRNSAdditional Listing
9th Mar 201610:46 amRNSDirector/PDMR Shareholding
29th Feb 201610:51 amRNSHolding(s) in Company
24th Feb 20167:00 amRNSFinal Results
10th Feb 201612:11 pmRNSDirector/PDMR Shareholding
4th Feb 20164:51 pmRNSHolding(s) in Company
2nd Feb 20169:59 amRNSCirc re Adoption of FRS 101
14th Jan 201610:38 amRNSDirector/PDMR Shareholding
4th Jan 20167:00 amRNSBlocklisting Interim Review
17th Dec 20154:13 pmRNSDirector/PDMR Shareholding
3rd Dec 20151:54 pmRNSHolding(s) in Company
30th Nov 20154:21 pmRNSHolding(s) in Company
13th Nov 20157:05 amRNSAppointment of Chairman-Designate
13th Nov 20157:00 amRNSQ3 Trading Update
10th Nov 20152:05 pmRNSDirector/PDMR Shareholding
5th Nov 20152:02 pmRNSHolding(s) in Company
27th Oct 20152:13 pmRNSDirector/PDMR Shareholding
15th Oct 20159:21 amRNSDirector/PDMR Shareholding
14th Oct 201510:29 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.